Specialty medical injectable medication program, requirement and policy updates February 2026

Review the following tables to determine changes to our specialty medical injectable medication programs and drug policy updates for February 2026.

Feb. 20, 2026

Review the following tables to determine changes to our specialty medical injectable medication programs and drug policy updates.

Review at Launch
The following specialty medical injectable medications have been added to Review at Launch:

Medication Name	HCPCs Code(s)
Exdensur (depemokimab-ulaa)	J3490/J3590/C9399
Nufymco®(ranibizumab-leyk) Biosimilar to Lucentis®	J3490/J3590/C9399

Note: Medications added to Review at Launch may not yet be available in the marketplace.

Review the UnitedHealthcare Commercial Plan Review at Launch Medication List.

For questions, please contact your broker or UnitedHealthcare representative.

Current employer group client or broker?

Access uhceservices to manage eligibility, view plan documents, request ID cards and more.

Sign in